- Report
- September 2022
- 80 Pages
Global
From €5472EUR$5,950USD£4,629GBP
- Report
- January 2022
- 112 Pages
Global
From €5472EUR$5,950USD£4,629GBP
- Report
- March 2025
- 200 Pages
Japan
From €2290EUR$2,490USD£1,937GBP
- Report
- November 2022
- 190 Pages
Global
From €2290EUR$2,490USD£1,937GBP
- Report
- April 2022
- 250 Pages
Asia Pacific
From €2290EUR$2,490USD£1,937GBP
- Report
- May 2021
Saudi Arabia
From €2106EUR$2,290USD£1,782GBP
- Report
- May 2023
- 180 Pages
Germany
From €2750EUR$2,990USD£2,326GBP
From €2290EUR$2,490USD£1,937GBP
- Report
- November 2021
- 118 Pages
Global
From €2290EUR$2,490USD£1,937GBP
- Report
- April 2024
- 91 Pages
Global
From €4553EUR$4,950USD£3,851GBP
- Report
- December 2023
- 41 Pages
United States
From €2253EUR$2,450USD£1,906GBP
- Report
- April 2023
- 57 Pages
Asia Pacific
From €4553EUR$4,950USD£3,851GBP
- Report
- April 2023
- 78 Pages
Global
From €4553EUR$4,950USD£3,851GBP
- Report
- December 2022
- 24 Pages
Global
From €2253EUR$2,450USD£1,906GBP
- Report
- November 2022
- 117 Pages
Global
From €4553EUR$4,950USD£3,851GBP
- Report
- September 2021
- 84 Pages
Global
From €4553EUR$4,950USD£3,851GBP
- Report
- August 2020
- 74 Pages
Global
From €2759EUR$3,000USD£2,334GBP
- Report
- August 2020
- 51 Pages
Global
From €2713EUR$2,950USD£2,295GBP
- Report
- April 2020
- 63 Pages
Global
- Report
- April 2020
- 65 Pages
Global

The Biotechnology market has been affected by the pandemic in a variety of ways. Companies in the sector have had to adjust their operations to meet the demands of the new environment. Many have shifted their focus to developing treatments and vaccines for the virus, while others have had to pivot their operations to meet the needs of the changing market. Companies have also had to adjust their supply chains to ensure the safety of their products and services.
The pandemic has also had an impact on the financial performance of biotechnology companies. Many have seen their stock prices decline due to the uncertainty of the market. Additionally, the pandemic has caused a decrease in research and development spending, as well as a decrease in venture capital investments.
Notable companies in the biotechnology market include Gilead Sciences, Moderna, Regeneron Pharmaceuticals, and Novavax. These companies have all been involved in the development of treatments and vaccines for the virus. Additionally, they have all seen their stock prices increase due to the pandemic. Show Less Read more